Home/ Supplements/ Vitamin K/ Vitamin K2 100 mcg

Vitamin K2 100 mcg

product on market Tablet or Pill Bronson Basics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is researched for its role in supporting bone health and regulating calcium distribution in the body. There is moderate evidence suggesting it works synergistically with Vitamin D to improve bone mineral density. This specific formulation provides a standard daily dose of the nutrient.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
120
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Microcrystalline Cellulose Stearic Acid Croscarmellose Sodium Magnesium Stearate Silicon Dioxide Hydroxypropyl Methylcellulose Polyethylene Glycol
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement for adults, take 1 tablet daily, preferably with a meal or as directed by a healthcare professional.

Warnings & Precautions

Warning: Do not take this product if you are pregnant or nursing. Consult a healthcare professional before taking this product if you have a medical condition or are taking medication, especially anticoagulant, and antiplatelet medications, have a bleeding disorder, or planning a medical procedure.

Discontinue use and consult a healthcare professional in case of adverse reaction. Do not use if seal under cap is broken or missing.

Keep out of reach of children.

Formulation Notes

MK-7

Supports bone health Cardiovascular support

GMO-free Gluten-free Soy-free

Lab Tested Made from High Quality Ingredients 365 Days 100% Money back Guaranteed

Additional Information

Store at room temperature.

Nutrition questions or comments? Call 1-800-235-3200 Mon.-Fri. 7 AM- 6 PM MST Sat. 8 AM-4:30 PM MST New

GMP Good Manufacturing Practice

Metadata

Product Details

UPC / SKUX003GAZAV1
DSLD Entry Date2024-08-22
Product TypeVitamin
FormTablet or Pill
DSLD ID317358
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.